AVRX Stock Price, News & Analysis

AVRX

Published by Stock Titan Data refreshed August 10, 2026

What Changed

Latest news August 10, 2026
Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001

Company Description

This page collects what Stock Titan holds for AVRX, including price data and latest news.

Stock Performance

—

-

-

-

Performance 1 year

-

-

Shares outstanding

Latest News

August 10, 2026

—

Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001

private placement

AVRX has 1 recent news article. Key topics include private placement. View all AVRX news →

SEC Filings

No SEC filings available for AVRX.